Autologous monocyte-derived dendritic cell therapy (National Academy of Sciences of Belarus)

N/A

Report date: 2025/12/31 20:01:55

Base Information

Drug NameAutologous monocyte-derived dendritic cell therapy (National Academy of Sciences of Belarus)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Source of cells > Monocyte-derivedCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsUrinary Bladder Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelarus

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNational Academy Of Sciences Of Belarus

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesInstitute Of Biophysics And Cell Engineering Of National Academy Of Sciences Of Belarus

Active IndicationsN/A

Inactive IndicationsUrinary Bladder Neoplasms

Other Information

ATC CodeN/A